Structural Genomics Consortium
Celia(Wenjun) Chen has held various important roles in research and customer service. Currently serving as a Research Technician at Ranomics and The Structural Genomics Consortium, Celia(Wenjun) has assisted in investigating the role of PRMT5 in cancer and drug screening for potential therapeutic probes. In the past, Celia(Wenjun) has also worked as a Clinical Research Assistant at the Centre for Addiction and Mental Health, examining smoking cessation medication. With a Bachelor of Science in Pharmacology and Toxicology and a Master of Science in Applied Clinical Pharmacology from the University of Toronto, Celia(Wenjun) Chen has a strong academic background to support their research pursuits.
Structural Genomics Consortium
The SGC catalyzes research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies.